198 related articles for article (PubMed ID: 22431082)
1. The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy.
Friedman SD; Poliachik SL; Carter GT; Budech CB; Bird TD; Shaw DW
Muscle Nerve; 2012 Apr; 45(4):500-6. PubMed ID: 22431082
[TBL] [Abstract][Full Text] [Related]
2. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
[TBL] [Abstract][Full Text] [Related]
3. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
5. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
[TBL] [Abstract][Full Text] [Related]
6. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
[TBL] [Abstract][Full Text] [Related]
7. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism.
Kan HE; Klomp DW; Wohlgemuth M; van Loosbroek-Wagemans I; van Engelen BG; Padberg GW; Heerschap A
NMR Biomed; 2010 Jul; 23(6):563-8. PubMed ID: 20175146
[TBL] [Abstract][Full Text] [Related]
8. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
9. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles.
Tasca G; Pescatori M; Monforte M; Mirabella M; Iannaccone E; Frusciante R; Cubeddu T; Laschena F; Ottaviani P; Ricci E
PLoS One; 2012; 7(6):e38779. PubMed ID: 22719944
[TBL] [Abstract][Full Text] [Related]
10. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
[TBL] [Abstract][Full Text] [Related]
11. FSHD-like patients without 4q35 deletion.
Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
[TBL] [Abstract][Full Text] [Related]
12. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].
Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163
[TBL] [Abstract][Full Text] [Related]
13. Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy.
van Overveld PG; Enthoven L; Ricci E; Rossi M; Felicetti L; Jeanpierre M; Winokur ST; Frants RR; Padberg GW; van der Maarel SM
Ann Neurol; 2005 Oct; 58(4):569-76. PubMed ID: 16178028
[TBL] [Abstract][Full Text] [Related]
14. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
[TBL] [Abstract][Full Text] [Related]
15. Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1.
Lareau-Trudel E; Le Troter A; Ghattas B; Pouget J; Attarian S; Bendahan D; Salort-Campana E
PLoS One; 2015; 10(7):e0132717. PubMed ID: 26181385
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD.
de Greef JC; Wohlgemuth M; Chan OA; Hansson KB; Smeets D; Frants RR; Weemaes CM; Padberg GW; van der Maarel SM
Neurology; 2007 Sep; 69(10):1018-26. PubMed ID: 17785671
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD).
Wood-Allum C; Brennan P; Hewitt M; Lowe J; Tyfield L; Wills A
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):188-91. PubMed ID: 15043716
[No Abstract] [Full Text] [Related]
18. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of translocation between chromosomes 4q and 10q in facioscapulohumeral muscular dystrophy].
Wang N; Wu ZY; Wang CD; Wang ZQ; Lin MT; Fang L; Murong SX
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):650-3. PubMed ID: 12887821
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M
Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
